DK0977582T3 - Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater - Google Patents

Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater

Info

Publication number: DK0977582T3
Authority: DK; Denmark
Prior art keywords: pharmaceuticals containing; iron preparations; containing erythropoietin; combination pharmaceuticals; combination
Prior art date: 1997-03-18

Application number

DK97914258T

Other languages

Danish (da)

English (en)

Inventor

Paul Lehmann

Original Assignee

Roche Diagnostics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-18

Filing date

1997-03-18

Publication date

2002-12-16

1997-03-18 Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh

2002-12-16 Application granted granted Critical

2002-12-16 Publication of DK0977582T3 publication Critical patent/DK0977582T3/da

Links

102000003951 Erythropoietin Human genes 0.000 title 1
108090000394 Erythropoietin Proteins 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940105423 erythropoietin Drugs 0.000 title 1
229940082629 iron antianemic preparations Drugs 0.000 title 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 2
VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 abstract 1
208000007502 anemia Diseases 0.000 abstract 1
238000001631 haemodialysis Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Zoology (AREA)
Hematology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Clamps And Clips (AREA)
Medicinal Preparation (AREA)

DK97914258T 1997-03-18 1997-03-18 Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater DK0977582T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP1997/001343 WO1998041226A1 (fr)	1997-03-18	1997-03-18	Preparations pharmaceutiques associees contenant de l'erythropoietine et preparations a base de fer

Publications (1)

Publication Number	Publication Date
DK0977582T3 true DK0977582T3 (da)	2002-12-16

Family

ID=8166555

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97914258T DK0977582T3 (da)	1997-03-18	1997-03-18	Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater

Country Status (19)

Country	Link
US (1)	US6710028B2 (fr)
EP (1)	EP0977582B1 (fr)
JP (1)	JP2000514092A (fr)
AT (1)	ATE222118T1 (fr)
AU (1)	AU726801B2 (fr)
BR (1)	BR9714632A (fr)
CA (1)	CA2284910C (fr)
CZ (1)	CZ296960B6 (fr)
DE (1)	DE59707988D1 (fr)
DK (1)	DK0977582T3 (fr)
ES (1)	ES2180958T3 (fr)
HU (1)	HU226204B1 (fr)
IL (2)	IL131959A0 (fr)
NO (1)	NO324661B1 (fr)
NZ (1)	NZ337465A (fr)
PL (1)	PL187479B1 (fr)
PT (1)	PT977582E (fr)
SI (1)	SI0977582T1 (fr)
WO (1)	WO1998041226A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7304150B1 (en)	1998-10-23	2007-12-04	Amgen Inc.	Methods and compositions for the prevention and treatment of anemia
US7459435B2 (en)	2002-08-29	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
US7459436B2 (en)	2002-11-22	2008-12-02	Hoffmann-La Roche Inc.	Treatment of disturbances of iron distribution
US20040198663A1 (en) *	2003-04-04	2004-10-07	Baker John E.	Method of treating cardiac ischemia by using erythropoietin
AU2003291796A1 (en) *	2003-06-27	2005-01-13	Igor A. Pomytkin	Synergistic compositions comprising erythropoietin and succinic acid (salt)
JP2007514673A (ja) *	2003-12-19	2007-06-07	エフ．ホフマン−ラ　ロシュ　アーゲー	慢性炎症性腸疾患の際の鉄分布障害の処置におけるエリスロポエチンの使用
US20080090765A1 (en) *	2006-05-25	2008-04-17	The Trustees Of Columbia University In The City Of New York	Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
EP3381445B1 (fr)	2007-11-15	2023-10-25	Amgen Inc.	Formulation aqueuse d'anticorps stabilisée par des antioxydants pour administration parentérale
EP2067752A1 (fr) *	2007-12-06	2009-06-10	Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO	Matériau de construction
US8536106B2 (en)	2010-04-14	2013-09-17	Ecolab Usa Inc.	Ferric hydroxycarboxylate as a builder
WO2011149962A1 (fr)	2010-05-24	2011-12-01	The Trustees Of Columbia University In The City Of New York	Proteines ngal mutantes et leurs utilisations
EP2925337B1 (fr)	2012-11-21	2019-07-03	The Trustees of Columbia University in the City of New York	Protéines ngal mutantes et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL77081A (en)	1984-12-04	1999-10-28	Genetics Inst	Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4745099A (en)	1985-02-06	1988-05-17	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical composition for the treatment of the anemia of malignant tumors
JP2858752B2 (ja) *	1987-04-10	1999-02-17	オーソ・フアーマシユーチカル・コーポレーシヨン	正常な哺乳動物のヘマトクリツト値の増大方法
GB9001987D0 (en) *	1990-01-29	1990-03-28	Janssen Pharmaceutica Nv	Improved cyclodextrin based erythropietin formulation
DE19535571A1 (de) *	1995-09-14	1997-03-20	Boehringer Mannheim Gmbh	Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
EP0885613A1 (fr) *	1997-06-21	1998-12-23	Roche Diagnostics GmbH	Application d'hémoglobine modifiée au traitement d'anémies et préparations mixtes à base d'hémoglobine modifiée et d'érythropoiétine
DE19734293A1 (de) *	1997-08-08	1999-02-11	Boehringer Mannheim Gmbh	Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US20020065214A1 (en) *	2000-11-29	2002-05-30	Adrian Iaina	Method of treating congestive heart failure
CA2431964C (fr) *	2000-12-20	2013-09-10	F. Hoffmann-La Roche Ag	Conjugues d'erythropoietine (pep) et de polyethylene glycol (peg)

1997
- 1997-03-18 NZ NZ337465A patent/NZ337465A/en not_active IP Right Cessation
- 1997-03-18 WO PCT/EP1997/001343 patent/WO1998041226A1/fr not_active Ceased
- 1997-03-18 ES ES97914258T patent/ES2180958T3/es not_active Expired - Lifetime
- 1997-03-18 AT AT97914258T patent/ATE222118T1/de active
- 1997-03-18 AU AU21572/97A patent/AU726801B2/en not_active Expired
- 1997-03-18 IL IL13195997A patent/IL131959A0/xx active IP Right Grant
- 1997-03-18 DE DE59707988T patent/DE59707988D1/de not_active Expired - Lifetime
- 1997-03-18 PT PT97914258T patent/PT977582E/pt unknown
- 1997-03-18 BR BR9714632-3A patent/BR9714632A/pt not_active Application Discontinuation
- 1997-03-18 DK DK97914258T patent/DK0977582T3/da active
- 1997-03-18 EP EP97914258A patent/EP0977582B1/fr not_active Expired - Lifetime
- 1997-03-18 HU HU0001409A patent/HU226204B1/hu unknown
- 1997-03-18 CA CA002284910A patent/CA2284910C/fr not_active Expired - Lifetime
- 1997-03-18 SI SI9730390T patent/SI0977582T1/xx unknown
- 1997-03-18 CZ CZ0330099A patent/CZ296960B6/cs not_active IP Right Cessation
- 1997-03-18 PL PL97335858A patent/PL187479B1/pl unknown
- 1997-03-18 JP JP10540046A patent/JP2000514092A/ja active Pending
1999
- 1999-09-16 IL IL131959A patent/IL131959A/en not_active IP Right Cessation
- 1999-09-17 NO NO19994511A patent/NO324661B1/no not_active IP Right Cessation
2001
- 2001-10-23 US US10/047,749 patent/US6710028B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU726801B2 (en)	2000-11-23
HU226204B1 (en)	2008-06-30
US20020094948A1 (en)	2002-07-18
HUP0001409A2 (en)	2001-03-28
CA2284910C (fr)	2003-01-28
PL335858A1 (en)	2000-05-22
ES2180958T3 (es)	2003-02-16
NO324661B1 (no)	2007-11-26
CA2284910A1 (fr)	1998-09-24
NZ337465A (en)	2002-04-26
PL187479B1 (pl)	2004-07-30
ATE222118T1 (de)	2002-08-15
NO994511D0 (no)	1999-09-17
NO994511L (no)	1999-09-17
DE59707988D1 (de)	2002-09-19
US6710028B2 (en)	2004-03-23
BR9714632A (pt)	2000-05-23
SI0977582T1 (en)	2002-12-31
WO1998041226A9 (fr)	1999-11-25
EP0977582A1 (fr)	2000-02-09
EP0977582B1 (fr)	2002-08-14
HUP0001409A3 (en)	2003-08-28
WO1998041226A1 (fr)	1998-09-24
CZ9903300A3 (cs)	2001-03-14
IL131959A0 (en)	2001-03-19
CZ296960B6 (cs)	2006-08-16
JP2000514092A (ja)	2000-10-24
PT977582E (pt)	2002-12-31
AU2157297A (en)	1998-10-12
IL131959A (en)	2006-12-31

Publication	Publication Date	Title
CA2234282A1 (fr)	1998-10-16	Complexes medicament/resine stabilises par des chelateurs
DK0851762T3 (da)	2002-08-12	Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
AU4254696A (en)	1996-06-19	Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
GEP20002331B (en)	2000-12-25	Alkylated Raphamicine Derivatives
DE69008010D1 (de)	1994-05-19	Sauerstoffdelignifizierung und enzymatische Behandlung.
ZA905312B (en)	1992-02-26	Combination therapy for prohylaxsis and/or treatment of benign prostatic hyperplasia
NO994511D0 (no)	1999-09-17	Farmasöytiske kombinerte preparater inneholdende erythropoietin og jern-preparater
AU1890295A (en)	1995-09-25	Piperidines and pyrrolidines
NO944764D0 (no)	1994-12-08	Inklusjonskomplekser i vandige opplösninger av benzotiofenforbindelser med vannopplöselige cyklodekstriner og farmasöytiske formuleringer og fremgangsmåter
IL87421A (en)	1992-12-01	Pharmaceutical compositions containing 5-amino (or substituted amino) - 1,2,3-triazoles
DK0996462T3 (da)	2004-11-29	Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
MY102323A (en)	1992-05-28	New ribofuranuronic acid derivatives
IL74949A (en)	1988-05-31	Iron complexes with hydroxypyrone or hydroxypyridone derivatives,their preparation and pharmaceutical compositions and containing them
KR960013376A (ko)	1996-05-22	철과 디프룩토오스를 함유하는 빈혈치료제
WO1991015466A3 (fr)	1991-11-28	Agents chelateurs
SI0736009T1 (en)	2003-04-30	N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
AU2904789A (en)	1989-07-19	Macrocyclic chelating agents and chelates thereof
GR3002381T3 (en)	1992-12-30	Use of a carboxylic acid in pharmaceutical preparations intended for topical application
TR199902305T2 (xx)	2000-03-21	Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
EP0827751A3 (fr)	1999-02-03	Composition médicinale qui contient de l'activateur de plasminogène tissulaire et de la nicotinamide
BG94567A (en)	1995-01-31	Medicaments for the treatment of aids and method for its application
MX9705119A (es)	1997-10-31	Interferona modificada quimicamente.